Co-Authors
This is a "connection" page, showing publications co-authored by Manuel Battegay and David Back.
Connection Strength
0.281
-
Prescribing in COVID-19 patients: Should we take into account inflammation? Br J Clin Pharmacol. 2021 03; 87(3):719-721.
Score: 0.225
-
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086.
Score: 0.057
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.